Customer & market partners
European Union
PAN-Europe customers and local market leaders across major and emerging EU territories.
- EU GMP
- GDP
Global Network
One Network. Multiple Possibilities.
From API sourcing and formulation development to manufacturing partnerships, product licensing, and global market access, we connect the right partners at the right stage of the pharmaceutical value chain. Our role is to simplify the journey from development to commercialization by bringing together reliable manufacturers, innovative R&D partners, and global pharmaceutical customers.
Customer & regulatory partners
United States
Commercial partners and regulatory support aligned to US FDA expectations.
- US FDA
- 505(b)(2)
Manufacturing & development base
India
API, granule, pellet and FDF manufacturing partners with regulated-market track records.
- API
- FDF
Emerging market access
Rest of world
Selective partnerships opening emerging markets for proprietary and partner products.
- Emerging
Partner categories
Who sits inside the ecosystem
Partner identities remain confidential until a structured introduction is agreed. What we publish is the shape of the network, not our partners' commercial positions.
CROs
Analytical, formulation and clinical development specialists.
CDMOs
Development and manufacturing partners for scale-up and commercial supply.
CMOs
Contract manufacturing capacity serving US and European markets.
Distribution partners
GDP-compliant routes to market and local licence holders.